This measure identifies patients with diabetes mellitus taking insulin that had evidence of self-monitoring blood glucose testing in last 12 reported months.
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisCare SettingNumerator
Did the patient fill a prescription for any of the following during the following time period: last 12 months of the report period through 90 days after the end of the report period?
? Glucometers (RX-175)
? Blood Glucose Test Strips (RX-176)
Time Window: 12 months prior to the end of the report period through 90 days after the end of the report periodDenominatorAdults with diabetes who are taking insulin as defined below:
Time Window:
1. The 24 months prior to the end of the report period is used to identify patients with diabetes.
2. The last 120 days of the report period through 90 days after the end of the report period is used to identify insulin using populationExclusions1. Absence of a prescription for Insulin (code set RX-59) during the following time period: last 120 days of the report period through 90 days after the end of the report period?
2. During the 12 months prior to the end of the report period, did the patient have 1 or more of the following services or events, where the diagnosis was Polycystic Ovaries (code set DX0312), Gestational Diabetes (DX0313), or Steroid-induced Diabetes (DX0314):
? Professional Encounter Code Set (code set PR0107, RV0107)
? Professional Supervision (code set PR0108)
? Facility Event – Confinement/Admission
? Facility Event – Emergency Room
? Facility Event – Outpatient SurgeryTesting Data Sources
- Measure StructureClinical Condition Topic AreaNational Quality Strategy PrioritiesEffective Communication and Care Coordination
- Risk Adjustment
- Current or planned use(s)Current Use(s)
- Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Endocrine Endorsement Maintenance ProjectInitial EndorsementEndorsement StatusLast UpdatedRemoval Date
- StewardSteward Organization Email